Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

TAK — Takeda Pharmaceutical Company Limited

UNDERVALUED (MOS +37.5%) · Quality 58/100

TAK - Takeda Pharmaceutical Company Limited
Data generated 2026-11-11 20:45 UTC (nightly scan, universe: Foreign US-listed).
Price: 20.83 USD
Intrinsic value: 33.32 USD
Margin of safety: +37.5%
Implied growth (reverse DCF): +2.9% (model assumes +10.9%)
Valuation: UNDERVALUED
Value Score: 33.5
Quality: 58/100
Moat score: 18.8 (erosion: watch)
UNDERVALUED (MOS +37.5%) - Quality 58/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/TAK
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

20.83

Intrinsic value

33.32

Margin of safety

+37.5%

Implied growth (reverse DCF)

+2.9%

model assumes +10.9%

Value Score

33.5

Quality

Psychology

-14.4

Discovery

7.8

price/volume attention only

Moat score

18.8

erosion: watch

Value Score: bottom 49% of Foreign US-listed · Quality: bottom 42%

Open the interactive Deep Dive for TAK →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/TAK - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is TAK undervalued?

As of 2026-11-11, TAK trades at 20.83 against a computed intrinsic value of 33.32 (+37.5% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Takeda Pharmaceutical Company Limited's Value Score?

Takeda Pharmaceutical Company Limited's Value Score is 33.5 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.